Differential Effects of GLP-1 Receptor Agonists on Cancer Risk in Obesity: A Nationwide Analysis of 1.1 Million Patients.
GLP-1 受體激動劑對肥胖癌症風險的差異性影響:110 萬患者的全國性分析。
Cancers (Basel) 2025-01-11
Increased Risk of Cancer-An Integral Component of the Cardio-Renal-Metabolic Disease Cluster and Its Management.
癌症風險增加——心腎代謝疾病群的重要組成部分及其管理
Cells 2025-04-25
Impact of GLP-1 receptor agonist-induced weight loss on 22 cancers in the next ten years using a Markov state-transition model - A UK weight and wellness cancer landscape analysis.
GLP-1 受體促效劑誘導體重減輕對未來十年內 22 種癌症的影響:採用 Markov 狀態轉換模型的英國體重與健康癌症現況分析
Cancer Epidemiol 2025-05-25
Anti-Obesity Medications and the Risk of Obesity-Related Cancers in Older Women: A Propensity Score Matching Analysis of 2007-2015 SEER-Medicare Data.
年長女性使用抗肥胖藥物與肥胖相關癌症風險:2007-2015 SEER-Medicare 資料的傾向分數配對分析
Cancers (Basel) 2025-05-28